GlassScriptPhysician profile
Sheila Razmzan
NPI 1861899239
$1,355.66
in general payments reported to CMS, 2019-2025
14 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $297 · 2023: $458 · 2024: $319 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $261.83 | 2022-2025 | Fetroja |
| Melinta Therapeutics, LLC | $255.28 | 2022-2024 | Kimyrsa, Rezzayo |
| Medtronic, INC. | $204.79 | 2024-2025 | Symplicity G3, Transorb |
| La Jolla Pharmaceutical Company | $143.01 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $123.36 | 2023 | |
| Merck Sharp & Dohme LLC | $94.58 | 2022-2025 | Zerbaxa, Recarbrio, Dificid |
| Haemonetics Corporation | $66.34 | 2023-2025 | Teg6s Hemostasis System |
| Csl Behring | $53.22 | 2022-2023 | Kcentra |
| Abbvie INC. | $43.42 | 2024 | |
| Teleflex LLC | $26.99 | 2024 | Arrow |
| Atricure, INC. | $24.47 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kci USA, INC. | $20.64 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Chiesi USA, INC. | $19.69 | 2022 | |
| Pfizer INC. | $18.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Razmzan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.